Business Context and Reporting Period
This Form 8-K Current Report was filed by Elevance Health, Inc. on March 2, 2026, regarding an event that occurred on February 27, 2026. The filing discloses a regulatory matter involving the Centers for Medicare & Medicaid Services (CMS) concerning the Company's Medicare Advantage-Prescription Drug (MA-PD) plans.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory disclosure under Item 8.01 and does not contain financial statement data.
Material Changes and Regulatory Action
- Proposed Sanctions: CMS notified Elevance of its intent to impose intermediate sanctions, including suspending enrollment of new Medicare beneficiaries into MA-PD plans and suspending certain communication activities with beneficiaries.
- Effective Date: The sanctions are scheduled to take effect on March 31, 2026, unless CMS determines the issues have been satisfactorily addressed.
- Scope of Impact: The suspension does not impact the benefits or plans of current MA-PD members.
- Cause: The proposed sanctions relate to alleged noncompliance with Medicare Advantage risk adjustment data submission requirements for dates of service prior to April 3, 2023.
- Company Response: The Company revised its practices in April 2023 following additional regulatory guidance and is currently engaging with CMS to address the concerns.
Outlook, Risks, and Management Commentary
Management states it is committed to working cooperatively with CMS to resolve the stated concerns. The filing includes extensive forward-looking statements cautioning that actual results may differ due to various risks, including:
- Trends in healthcare costs and utilization rates.
- Regulatory changes and enforcement actions impacting Medicare and Medicaid programs.
- Risks associated with non-compliance with complex regulations.
- Potential impacts on Star Ratings and quality scores.
- General economic conditions, competitive pressures, and litigation risks.
Investor Verification Checklist
- Verify the status of the CMS investigation and whether the March 31, 2026, effective date for sanctions is upheld or rescinded.
- Assess the potential financial impact of a suspension on new MA-PD enrollment growth.
- Review the Company's specific remediation steps taken since April 2023 regarding risk adjustment data submissions.
- Monitor for any updates on CMS Star Ratings or quality scores that could affect future reimbursement rates.
- Check for subsequent filings regarding the resolution of the alleged noncompliance.